Thus, we assessed the activation of ERK1/2, JNK, and p38, and found that the ERK1/2, JNK, and p38 pathways were all inhibited, along with increased GST-pi in DEN/HFD-induced HCC treated with RES or NAC (Figure 8A). This evidence concerns the gene MAPK3 and hepatocellular carcinoma.